BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 1372222)

  • 1. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses.
    Balfour JA; Faulds D
    Drugs; 1992 Feb; 43(2):259-84. PubMed ID: 1372222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terbinafine. An update of its use in superficial mycoses.
    McClellan KJ; Wiseman LR; Markham A
    Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD; Plosker GL
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and tolerability of terbinafine (Lamisil)--a new topical and systemic fungicidal drug for treatment of dermatomycoses.
    Villars V; Jones TC
    Clin Exp Dermatol; 1989 Mar; 14(2):124-7. PubMed ID: 2689015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.
    Davis R; Balfour JA
    Pharmacoeconomics; 1995 Sep; 8(3):253-69. PubMed ID: 10155621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral terbinafine: a new antifungal agent.
    Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1997 Apr; 31(4):445-56. PubMed ID: 9101008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terbinafine: a review of its use in onychomycosis in adults.
    Darkes MJ; Scott LJ; Goa KL
    Am J Clin Dermatol; 2003; 4(1):39-65. PubMed ID: 12477372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.
    Haria M; Bryson HM; Goa KL
    Drugs; 1996 Apr; 51(4):585-620. PubMed ID: 8706596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous mycoses in children.
    Elewski BE
    Br J Dermatol; 1996 Jun; 134 Suppl 46():7-11: discussion 37-8. PubMed ID: 8763460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open clinical study of the efficacy and safety of terbinafine cream 1% in children with tinea corporis and tinea cruris.
    Bakos L; Brito AC; Castro LC; Gontijo B; Lowy G; Reis CM; Ribeiro AM; Souza FH; Villar Mdo L; Zaitz C
    Pediatr Infect Dis J; 1997 Jun; 16(6):545-8. PubMed ID: 9194102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butenafine and superficial mycoses: current status.
    Singal A
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):999-1005. PubMed ID: 18624686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients.
    Millikan LE
    Cutis; 2001 Jul; 68(1 Suppl):6-14. PubMed ID: 11499333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral terbinafine (Lamisil) in the treatment of fungal infections of the skin and nails.
    Roberts DT
    Dermatology; 1997; 194 Suppl 1():37-9. PubMed ID: 9154400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special features of the clinical use of oral terbinafine in the treatment of fungal diseases.
    Villars VV; Jones TC
    Br J Dermatol; 1992 Feb; 126 Suppl 39():61-9. PubMed ID: 1543676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral therapy of common superficial fungal infections of the skin.
    Lesher JL
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 2):S31-4. PubMed ID: 10367914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of terbinafine in rare and refractory mycoses.
    Revankar SG; Nailor MD; Sobel JD
    Future Microbiol; 2008 Feb; 3(1):9-17. PubMed ID: 18230029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on antifungal therapy with terbinafine.
    Gianni C
    G Ital Dermatol Venereol; 2010 Jun; 145(3):415-24. PubMed ID: 20461049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-duration therapy with terbinafine 1% cream in dermatophyte skin infections.
    Evans EG; Seaman RA; James IG
    Br J Dermatol; 1994 Jan; 130(1):83-7. PubMed ID: 8305323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.